0000950123-25-000263.txt : 20250114 0000950123-25-000263.hdr.sgml : 20250114 20250113214429 ACCESSION NUMBER: 0000950123-25-000263 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250114 DATE AS OF CHANGE: 20250113 EFFECTIVENESS DATE: 20250114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-535076 FILM NUMBER: 25527558 BUSINESS ADDRESS: STREET 1: 45 LIBERTY BLVD. STREET 2: SUITE 230 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 45 LIBERTY BLVD. STREET 2: SUITE 230 CITY: MALVERN STATE: PA ZIP: 19355 D 1 primary_doc.xml X0708 D LIVE 0001563577 Galera Therapeutics, Inc. 45 Liberty Boulevard Suite 230 MALVERN PA PENNSYLVANIA 19355 612-725-1500 DELAWARE None None Corporation true J. Mel Sorensen c/o Galera Therapeutics, Inc. 45 Liberty Boulevard, Suite 230 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Joel Sussman c/o Galera Therapeutics, Inc. 45 Liberty Boulevard, Suite 230 Malvern PA PENNSYLVANIA 19355 Executive Officer Lawrence Alleva c/o Galera Therapeutics, Inc. 45 Liberty Boulevard, Suite 230 Malvern PA PENNSYLVANIA 19355 Director Nancy T. Chang c/o Galera Therapeutics, Inc. 45 Liberty Boulevard, Suite 230 Malvern PA PENNSYLVANIA 19355 Director Michael R. Friedman c/o Galera Therapeutics, Inc. 45 Liberty Boulevard, Suite 230 Malvern PA PENNSYLVANIA 19355 Director Kevin Lokay c/o Galera Therapeutics, Inc. 45 Liberty Boulevard, Suite 230 Malvern PA PENNSYLVANIA 19355 Director Pharmaceuticals Decline to Disclose 06b false 2024-12-30 false true true true Issued in connection with merger transaction between Galera Therapeutics, Inc. and Nova Pharmaceuticals, Inc., as further disclosed in a current report on Form 8-K filed on December 31, 2024. 0 2885000 2885000 0 false 8 0 0 0 false Galera Therapeutics, Inc. /s/ J. Mel Sorensen, M.D. J. Mel Sorensen, M.D. President & Chief Executive Officer 2025-01-13